Angiotensin II Receptor Blocker and Long-Acting Calcium Channel Blocker Combination Therapy Decreases Urinary Albumin Excretion While Maintaining Glomerular Filtration Rate

Hypertension Research - United Kingdom
doi 10.1038/hr.2011.101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Circadian Rhythm of Urinary Potassium Excretion During Treatment With an Angiotensin Receptor Blocker

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2013English

The Lack of Benefit of a Combination of an Angiotensin Receptor Blocker and Calcium Channel Blocker on Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2013English

A Different Dihydropyridine Calcium Channel Blocker in Hypertensive Patients Who Developed Pedal Edema on Dihydropyridine Calcium Channel Blocker Therapy

Cumhuriyet Medical Journal
Medicine
2014English

Age-Related Difference in the Sleep Pressure-Lowering Effect Between an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensives: The ACS1 Study

Hypertension
Internal Medicine
2015English

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients With Hypertension

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2010English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2014English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2015English

The Importance of Early Antihypertensive Efficacy: The Role of Angiotensin II Receptor Blocker Therapy

Journal of Human Hypertension
Internal Medicine
2006English

A Case of Combined Use of an Angiotensin II Receptor Blocker and a Calcium Blocker to Prevent Recurrence of Proteinuria, Enabling Continued Bevacizumab Treatment

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy